YU2397A - 2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining - Google Patents

2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining

Info

Publication number
YU2397A
YU2397A YU2397A YU2397A YU2397A YU 2397 A YU2397 A YU 2397A YU 2397 A YU2397 A YU 2397A YU 2397 A YU2397 A YU 2397A YU 2397 A YU2397 A YU 2397A
Authority
YU
Yugoslavia
Prior art keywords
phenyl
aroylbenzothiophenes
medicaments
obtaining
hexamethyleneimino
Prior art date
Application number
YU2397A
Other languages
English (en)
Serbo-Croatian (sh)
Serbian (sr)
Inventor
Maria Luisa Brandi
Francesco Tonelli
Original Assignee
Eli Lilly Company
Lilly Corporate Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603150.5A external-priority patent/GB9603150D0/en
Application filed by Eli Lilly Company, Lilly Corporate Center filed Critical Eli Lilly Company
Publication of YU2397A publication Critical patent/YU2397A/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
YU2397A 1996-01-29 1997-01-24 2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining YU2397A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1077296P 1996-01-29 1996-01-29
GBGB9603150.5A GB9603150D0 (en) 1996-02-15 1996-02-15 Methods of inhibiting colon tumors

Publications (1)

Publication Number Publication Date
YU2397A true YU2397A (en) 1999-11-22

Family

ID=26308709

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2397A YU2397A (en) 1996-01-29 1997-01-24 2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining

Country Status (19)

Country Link
EP (1) EP0921799A4 (ru)
JP (1) JP2000503994A (ru)
KR (1) KR19990082054A (ru)
CN (1) CN1209745A (ru)
AR (1) AR010978A1 (ru)
AU (1) AU707892B2 (ru)
BR (1) BR9700778A (ru)
CO (1) CO4761062A1 (ru)
CZ (1) CZ235498A3 (ru)
EA (1) EA001104B1 (ru)
ID (1) ID15917A (ru)
IL (1) IL125521A (ru)
MX (1) MX9806036A (ru)
NO (1) NO983451D0 (ru)
NZ (1) NZ331105A (ru)
PL (1) PL328147A1 (ru)
TW (1) TW446560B (ru)
WO (1) WO1997026877A1 (ru)
YU (1) YU2397A (ru)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
CA2118096A1 (en) * 1993-10-15 1995-04-16 Srinivasan Chandrasekhar Methods for treating resistant neoplasms
US5574047A (en) * 1993-12-21 1996-11-12 Eli Lilly And Company Methods of inhibiting imperfect tissue repair

Also Published As

Publication number Publication date
PL328147A1 (en) 1999-01-18
AU707892B2 (en) 1999-07-22
AR010978A1 (es) 2000-08-02
EA199800677A1 (ru) 1999-02-25
TW446560B (en) 2001-07-21
EA001104B1 (ru) 2000-10-30
CN1209745A (zh) 1999-03-03
AU2123997A (en) 1997-08-20
KR19990082054A (ko) 1999-11-15
JP2000503994A (ja) 2000-04-04
EP0921799A1 (en) 1999-06-16
EP0921799A4 (en) 2002-03-13
MX9806036A (es) 1998-11-29
CZ235498A3 (cs) 1999-02-17
NO983451L (no) 1998-07-27
ID15917A (id) 1997-08-21
NZ331105A (en) 2000-06-23
BR9700778A (pt) 1998-10-06
IL125521A (en) 2001-11-25
CO4761062A1 (es) 1999-04-27
WO1997026877A1 (en) 1997-07-31
IL125521A0 (en) 1999-03-12
NO983451D0 (no) 1998-07-27

Similar Documents

Publication Publication Date Title
YU35697A (en) Substituted 6,6-hetero-bicyclic derivatives
MY132251A (en) Methods of inhibiting cell-cell adhesion
DK0651999T3 (da) Fremgangsmåder til inhibering af livmoderfibrose
MX9701329A (es) Metodos para la inhibicion de la replicacion viral.
ES2147399T3 (es) Nuevos derivados de 2,3,5-trimetil-4-hidroxianilidas, su preparacion y su aplicacion terapeutica.
MX9701325A (es) Metodos para inhibir la mucositis ulcerativa.
MX9701360A (es) Metodos para la inhibicion de la desmielinizacion y las enfermedades de la dismielinizacion.
UA32427C2 (ru) Применение бензотиофенов или их фармацевтически приемлемых солей или сольватов для угнетения ангиогенеза и/или ангиогенных болезней
NO944930D0 (no) Hemming av dysfunksjonell uterin blödning
RS49965B (sr) Supstituisani bisindolmaleimidi za inhibiciju ćelijske proliferacije
DK0652002T3 (da) Anvendelse af 2-phenyl-3-aroylebenzothiophener til fremstilling af et medikament til hæmning af brusknedbrydning
DK0659411T3 (da) Fremgangsmåde til forøgelse af libido hos kvinder efter menopausen
DK0659413T3 (da) Inhibering af CNS-problemer hos postmenopausale kvinder
FR2702477B1 (fr) Dérivés de benzoxazine, leur préparation et leur application en thérapeutique.
EA199800015A1 (ru) Способ ингибирования меланомы
YU6996A (sh) Upotreba benzotiofena za dobijanje leka
TR199802456T2 (xx) Yeni pirol t�revleri.
YU2397A (en) 2-phenyl-3-aroylbenzothiophenes using for medicaments obtaining
YU55495A (sh) Upotreba benzotiofena za dobijanje leka
MX9701333A (es) Metodos para inhibir el daño neuronal.
MX9702148A (es) Metodos para inhibir la mitosis endometrial.
MX9701327A (es) Metodos para inhibir el cancer endometrial.
DE69806705D1 (de) Benzo(b)thiophene Derivaten zur Verringerung der Blutplätchenzahl
RS50449B (sr) Supstituisani bisindolilmaleimidi za inhibiciju proliferacije ćelija
DK0771201T3 (da) Anvendelse af 2-phenyl-3-aroylbenzothiophener til fremstilling af et medikament til inhibering af primær endometrisk hyperplasi